Cita APA

Zhang, G., Guo, D., Dash, P. K., Araínga, M., Wiederin, J. L., Haverland, N. A., . . . Gendelman, H. E. (2015). The Mixed Lineage Kinase-3 Inhibitor URMC-099 Improves Therapeutic Outcomes for Long-Acting Antiretroviral Therapy. Nanomedicine.

Citación estilo Chicago

Zhang, Gang, et al. "The Mixed Lineage Kinase-3 Inhibitor URMC-099 Improves Therapeutic Outcomes for Long-Acting Antiretroviral Therapy." Nanomedicine 2015.

Cita MLA

Zhang, Gang, et al. "The Mixed Lineage Kinase-3 Inhibitor URMC-099 Improves Therapeutic Outcomes for Long-Acting Antiretroviral Therapy." Nanomedicine 2015.